FI960184L - Förfarande för tillverkning av HIV-proteasinhibitorer - Google Patents
Förfarande för tillverkning av HIV-proteasinhibitorer Download PDFInfo
- Publication number
- FI960184L FI960184L FI960184A FI960184A FI960184L FI 960184 L FI960184 L FI 960184L FI 960184 A FI960184 A FI 960184A FI 960184 A FI960184 A FI 960184A FI 960184 L FI960184 L FI 960184L
- Authority
- FI
- Finland
- Prior art keywords
- protease inhibitors
- hiv protease
- preparing hiv
- preparing
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9322593A | 1993-07-16 | 1993-07-16 | |
US9322593 | 1993-07-16 | ||
US08/187,664 US5463067A (en) | 1993-07-16 | 1994-01-26 | Process for making HIV protease inhibitors |
US18766494 | 1994-01-26 | ||
US9407706 | 1994-07-11 | ||
PCT/US1994/007706 WO1995002584A2 (en) | 1993-07-16 | 1994-07-11 | Process for making hiv protease inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
FI960184A0 FI960184A0 (sv) | 1996-01-15 |
FI960184L true FI960184L (sv) | 1996-03-14 |
FI119473B FI119473B (sv) | 2008-11-28 |
Family
ID=26787287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI960184A FI119473B (sv) | 1993-07-16 | 1996-01-15 | Förfarande för tillverkning av HIV-proteasinhibitorer |
Country Status (22)
Country | Link |
---|---|
US (2) | US5491238A (sv) |
EP (1) | EP0708762B1 (sv) |
JP (1) | JP3547136B2 (sv) |
CN (2) | CN1066723C (sv) |
AT (1) | ATE200079T1 (sv) |
AU (1) | AU676079B2 (sv) |
CZ (1) | CZ293953B6 (sv) |
DE (1) | DE69426979T2 (sv) |
DK (1) | DK0708762T3 (sv) |
ES (1) | ES2155091T3 (sv) |
FI (1) | FI119473B (sv) |
GR (1) | GR3035645T3 (sv) |
HU (1) | HUT74583A (sv) |
IL (1) | IL110342A (sv) |
LV (1) | LV12825B (sv) |
NO (1) | NO306297B1 (sv) |
NZ (1) | NZ269904A (sv) |
PL (1) | PL179039B1 (sv) |
PT (1) | PT708762E (sv) |
RU (1) | RU2125561C1 (sv) |
SK (1) | SK282616B6 (sv) |
WO (1) | WO1995002584A2 (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Formation and resolution of 2-tert-butylcarboxamido-piperazine |
IL111584A0 (en) * | 1993-11-18 | 1995-01-24 | Merck & Co Inc | Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them |
US5792869A (en) * | 1994-11-04 | 1998-08-11 | Yamakawa Chemical Industry Co., Ltd | Process for preparing optically active piperazine derivatives and Intermediates for preparation |
DE4446025A1 (de) * | 1994-12-22 | 1996-06-27 | Basf Ag | 2-Caroxamido-1,4,5,6-tetrahydropyrazine |
EP1125930A1 (de) * | 1995-05-23 | 2001-08-22 | Lonza Ag | Optisch aktive 2-Piperazincarbonsäurederivate und Verfahren zu ihrer Herstellung |
EP0744401B1 (de) * | 1995-05-23 | 2001-11-21 | Lonza Ag | Verfahren zur Herstellung von optisch aktiven 2-Piperazincarbonsäurederivaten |
CA2201218C (en) * | 1996-04-23 | 2004-09-28 | Rudolf Fuchs | Process for the preparation of optically active piperazine-2-carboxylic acid derivatives |
US6645961B1 (en) | 1997-03-07 | 2003-11-11 | Merck & Co., Inc. | Dry granulation formulation for an HIV protease inhibitor |
US6482952B2 (en) | 2000-06-20 | 2002-11-19 | Merck & Co., Inc. | Process for preparing acetonides |
US7218837B2 (en) | 2000-09-25 | 2007-05-15 | Victor Company Of Japan, Ltd. | Program-signal recording and reproducing apparatus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2052907A1 (en) * | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
US5169952A (en) * | 1991-07-02 | 1992-12-08 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides |
CA2072237A1 (en) * | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral -amino epoxides |
-
1994
- 1994-07-11 AT AT94922511T patent/ATE200079T1/de not_active IP Right Cessation
- 1994-07-11 JP JP50463295A patent/JP3547136B2/ja not_active Expired - Fee Related
- 1994-07-11 HU HU9600077A patent/HUT74583A/hu unknown
- 1994-07-11 CN CN94193304A patent/CN1066723C/zh not_active Expired - Fee Related
- 1994-07-11 EP EP94922511A patent/EP0708762B1/en not_active Expired - Lifetime
- 1994-07-11 DE DE69426979T patent/DE69426979T2/de not_active Expired - Lifetime
- 1994-07-11 PT PT94922511T patent/PT708762E/pt unknown
- 1994-07-11 WO PCT/US1994/007706 patent/WO1995002584A2/en active IP Right Grant
- 1994-07-11 NZ NZ269904A patent/NZ269904A/en not_active IP Right Cessation
- 1994-07-11 RU RU96103642A patent/RU2125561C1/ru not_active IP Right Cessation
- 1994-07-11 SK SK55-96A patent/SK282616B6/sk not_active IP Right Cessation
- 1994-07-11 AU AU73588/94A patent/AU676079B2/en not_active Ceased
- 1994-07-11 ES ES94922511T patent/ES2155091T3/es not_active Expired - Lifetime
- 1994-07-11 PL PL94312613A patent/PL179039B1/pl not_active IP Right Cessation
- 1994-07-11 CZ CZ1996131A patent/CZ293953B6/cs not_active IP Right Cessation
- 1994-07-11 DK DK94922511T patent/DK0708762T3/da active
- 1994-07-17 IL IL11034294A patent/IL110342A/en not_active IP Right Cessation
-
1995
- 1995-06-02 US US08/458,379 patent/US5491238A/en not_active Expired - Lifetime
- 1995-06-21 US US08/459,069 patent/US5496948A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 NO NO960168A patent/NO306297B1/no not_active IP Right Cessation
- 1996-01-15 FI FI960184A patent/FI119473B/sv active IP Right Grant
-
1999
- 1999-08-10 CN CNB991117905A patent/CN1192014C/zh not_active Expired - Fee Related
-
2001
- 2001-03-29 GR GR20010400119T patent/GR3035645T3/el unknown
-
2002
- 2002-03-15 LV LVP-02-39A patent/LV12825B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0722439T3 (da) | HIV-proteaseinhibitorer | |
FI962069L (sv) | Förfarande för framställning av karpolaktam | |
FI956135A0 (sv) | Separeringsförfarande | |
AU9122391A (en) | Hiv protease inhibitors | |
FI962488L (sv) | HIV proteas inhibitorer | |
FI955800L (sv) | Metod att framställa aminoalkylguanidiner | |
FI963054L (sv) | Förfarande för framställning av HIV proteas inhibitorer | |
FI931850L (sv) | Foerfarande foer framstaellning av en mellanprodukt | |
FI960184L (sv) | Förfarande för tillverkning av HIV-proteasinhibitorer | |
FI960206L (sv) | Förfarande för framställning av HIV-proteasinhibitorer | |
FI942102L (sv) | Förfarande för framställning av aluminoxaner | |
ZA945234B (en) | Process for making HIV protease inhibitors | |
EP0443560A3 (en) | Hiv protease inhibitors | |
EE04750B1 (et) | HIV-proteaasi inhibiitorite valmistamismeetod | |
EP0594586A4 (en) | Hiv protease inhibitors | |
MX9100121A (es) | Inhibidores de proteasas asparticas | |
FI954786L (sv) | Förfarande för framställning av aminometanfosfonsyra | |
DK1361216T3 (da) | Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor | |
FI934516L (sv) | Förfarande för lokalisering av tvärskärningar | |
NO920023D0 (no) | Hiv-proteaseinhibitorer | |
SG49247A1 (en) | Hiv protease inhibitors | |
ZA919721B (en) | Hiv protease inhibitors | |
HU0900220D0 (en) | Hiv protease inhibitors | |
FI955027L (sv) | Förfarande för framställning av en mellanprodukt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 119473 Country of ref document: FI |
|
PC | Transfer of assignment of patent |
Owner name: MERCK SHARP & DOHME CORP. Free format text: MERCK SHARP & DOHME CORP. |